verve therapeutics lilly - Search News

Order byBest matchMost fresh

News

Eli Lilly nears $1.3B deal for Verve Therapeutics

· 5h · on MSN

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

Continue reading

· 3h · on MSN

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

· 8h · on MSN

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

2h

Verve: Eli Lilly Acquisition Based On One-Time GalNAc PCSK9 Gene Editing Program

Eli Lilly acquires Verve Therapeutics, Inc. for $1B to advance gene-editing therapies like VERVE-102, targeting ASCVD. Click ...

7hon MSN

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results